Hyperhomocysteinemia is common in patients with end-stage renal disease. It is one of the risk factors for cardiovascular disease. We evaluated the effect of different doses of folic acid on serum homocysteine level in patients on hemodialysis.
MATERIALS AND METHODS
Patients on maintenance hemodialysis were randomized into 4 groups to receive… (More)